Spineart Marks Ti-Life Technology Cage Milestone

Spineart has sold 100,000 Ti-LIFE Technology cages worldwide, the company announced today.

Launched in July 2016, Spineart’s Ti-LIFE Technology is based on a unique proprietary algorithm associated with a 3D printing manufacturing process. Ti-LIFE is featured in various Spineart surgical implants, including posterior, lateral, and cervical cages—hollow interbody devices used in spinal fusion surgeries. These cages act as a space holder between the vertebrae, helping decompress the spinal cord and nerve root.

“Since its launch in 2016, Spineart’s Ti-Life Technology has contributed significantly to setting a new benchmark in spinal fusion surgery around the world,” Spineart CEO Jerome Trividic said. “As we progress towards the 20-year anniversary of the founding of our company, this latest milestone reflects our commitment to transforming spine surgery and improving patient lives, as well as Ti-LIFE’s excellent surgical track record.”

Ti-LIFE’s micro-porous structure closely mimics natural trabecular bone architecture and is designed to promote osseous in-growth and cell colonization once implanted. Ti-LIFE Technology cages have been shown to outperform other materials, demonstrating early and robust osseointegration without any bone graft or additive osteoinductive agents in just eight weeks.¹

“Spineart’s Ti-LIFE Technology offers significant improvements over traditional titanium implants, with better osseointegration, customizable mechanical properties, and improved imaging capabilities, all of which contribute to enhanced patient outcomes in spinal fusion surgery,” stated Joseph Laratta, M.D., a minimally invasive orthopedic spine surgeon at the Neck and Back Institute of Kentucky.

“Surpassing the 100,000 sales milestone for our Ti-LIFE Technology cages is a powerful demonstration of our strong growth to date as well as our future potential. Thank you to our team, investors, partners, surgeons and customers, each of whom have worked alongside us to reach this goal,” Spineart Chief Commercial Officer Alessia Erlingher concluded.

Spineart is a global company developing procedural spinal surgery solutions and digital technologies. The company was awarded the “Prix de l’Economie Genevoise 2022” for its contribution to technological and scientific innovations, commercial activities, job creation, and ESG principles.

Reference
¹ Joseph L. Laratta, M.D. et al. 3D-printed titanium cages without bone graft outperform PEEK cages with autograft in an animal model. The Spine Journal. 2021; DOI.